A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1997
11/20/1997	WO1997042958A1 Treatment of asthma and airway diseases
11/20/1997	WO1997042957A1 Pharmaceutical compositions comprising a xanthine and a catechin
11/20/1997	WO1997042956A1 Didhydropyrimidines and uses thereof
11/20/1997	WO1997042955A1 Compositions comprising sodium channel activators and local anesthetics
11/20/1997	WO1997042954A1 Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases
11/20/1997	WO1997042953A1 Use of brequinar and derivatives in chronic rejection of allografts and xenotransplantation
11/20/1997	WO1997042952A1 Percutaneous tape preparation containing fentanyl
11/20/1997	WO1997042951A1 Methods of identifying modulators of perivascular sensory nerve ca2+ receptors
11/20/1997	WO1997042950A1 Method for treating cocaine and amphetamine dependency
11/20/1997	WO1997042948A1 7-o-methoxymethyl paclitaxel
11/20/1997	WO1997042947A1 Methods of treating type i hypersensitivity using monophosphoryl lipid a
11/20/1997	WO1997042946A1 ALPHA BLOCKERS (e.g. MOXISYLYTE AND/OR DERIVATIVES THEREOF) FOR TREATING ERECTILE DYSFUNCTION
11/20/1997	WO1997042945A1 Oral pharmaceutical compositions
11/20/1997	WO1997042944A1 Topical composition
11/20/1997	WO1997042943A1 Oral rehydration product comprising glutamine
11/20/1997	WO1997042942A1 Topical medicament comprising phenolic biocide and choline
11/20/1997	WO1997042941A2 Buccal delivery system
11/20/1997	WO1997042939A1 Liposomal antineoplaston therapies with markedly improved antineoplastic activity
11/20/1997	WO1997042936A1 Freeze dried liposome encapsulated amphiphilic drug compositions and a process for the preparation thereof
11/20/1997	WO1997042929A1 Cosmetic composition for rejuvenation of skin without skin irritation
11/20/1997	WO1997042825A1 Antimicrobial peroxidase compositions
11/20/1997	WO1997038664A3 A method of treating cancer
11/20/1997	WO1997035994A3 Cytochrome p450 transducing retroviral vectors
11/20/1997	WO1997035538A3 Tumor necrosis factor alpha convertase
11/20/1997	WO1997034587A3 Transdermal device
11/20/1997	WO1997030677A3 Pentafluorobenzenesulfonamides and analogs
11/20/1997	DE19632823C1 Complexes of (+)-S-adenosyl-methionine and 3'-azido-2',3'-di:deoxy nucleoside compounds
11/20/1997	DE19619614A1 New sulphonamide derivatives of chroman
11/20/1997	DE19613976C1 Thalidomid-Prodrugs mit immunmodulatorischer Wirkung Thalidomide prodrugs with immunomodulatory effect
11/20/1997	CA2255685A1 Chitosan related compositions for delivery of nucleic acids into a cell
11/20/1997	CA2255589A1 Polyhydroxyphenol derivatives and preventive and therapeutic agents for bone and cartilage diseases containing the same
11/20/1997	CA2254878A1 Topical medicament comprising phenolic biocide and choline
11/20/1997	CA2254343A1 Inhibitors of picornavirus 3c proteases and methods for their use and preparation
11/20/1997	CA2254126A1 Ethene containing solutions and use thereof in methods of therapy or prophylaxis
11/20/1997	CA2254122A1 Synthetic inhibitors of hepatitis c virus ns3 protease
11/20/1997	CA2254120A1 Substituted 1, 3-benzodioxoles
11/20/1997	CA2253974A1 Freeze dried liposome encapsulated amphiphilic drug compositions and a process for the preparation thereof
11/20/1997	CA2253927A1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
11/20/1997	CA2253876A1 Indole derivatives useful as endothelin receptor antagonists
11/20/1997	CA2253862A1 Dihydropyrimidines and uses thereof
11/20/1997	CA2253836A1 Antithrombotic materials and methods
11/20/1997	CA2253802A1 Benzofurans and benzopyrans as chronobiological agents
11/20/1997	CA2253652A1 Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
11/20/1997	CA2253590A1 Inhibitors of the production of s-cd23 and the secretion of tnf
11/20/1997	CA2253566A1 Arylalkylpiperazine compounds as antioxidants
11/20/1997	CA2253463A1 8-hydrocarbyl substituted benzodizocine derivatives, their preparation and their use as protein kinase c (=pkc) modulators
11/20/1997	CA2253443A1 7-o-methoxymethyl paclitaxel
11/20/1997	CA2253365A1 Administration of histamine for therapeutic purposes
11/20/1997	CA2253289A1 Emergency contraceptive kit
11/20/1997	CA2252583A1 Anticonvulsant pyridinyl benzamide derivatives
11/20/1997	CA2251704A1 Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases
11/20/1997	CA2251547A1 Recombinant neospora antigens and their uses
11/20/1997	CA2247392A1 Vehicle for the transport of molecular substances
11/20/1997	CA2226834A1 A tape formulation for percutaneous administration containing fentanyl
11/19/1997	EP0807683A2 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
11/19/1997	EP0807633A2 Novel 2,3-disubstituted-(5,6)- heteroarylfused-pyrimidine-4-ones
11/19/1997	EP0807629A1 Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents aswell as medicaments containing them
11/19/1997	EP0807628A1 Aromatic compound and pharmaceutical composition
11/19/1997	EP0807627A2 Anilide compounds as ACAT inhibitors
11/19/1997	EP0807624A2 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
11/19/1997	EP0807621A1 Derivatives of phenylglycine and use thereof as pharmaceuticals
11/19/1997	EP0807440A2 Chlorhexidine gluconate-containing stabilized aqueous pharmaceutical preparations
11/19/1997	EP0807439A2 Method of treating sepsis and adult respiratory distress syndrome
11/19/1997	EP0807437A1 Polyacrylilic and polymethacrylic acid containing compositions with antiadhesion properties
11/19/1997	EP0807436A1 Muscular dystrophy progression depressant
11/19/1997	EP0807435A2 Indirect HMG-CoA-reductase inhibitor
11/19/1997	EP0807434A1 Anti-inflammatory eyedrops
11/19/1997	EP0807431A2 Process for the manufacture of carotenoid compositions
11/19/1997	EP0807430A2 Medicinal speciality for controlling the birth-rate of birds, and a method for its manufacture
11/19/1997	EP0807429A1 Cosmetic composition with retinol unsaturated fatty acid esters
11/19/1997	EP0807185A1 Antitumor and anticholesterol preparations containing a lipoteichoic acid from steptococcus
11/19/1997	EP0807183A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
11/19/1997	EP0807176A2 Monoclonal antibody 1a7 and use for the treatment of melanoma and small cell carcinoma
11/19/1997	EP0807115A1 High molecular weight polymer-based prodrugs
11/19/1997	EP0807114A1 Bridged indoles as matrix metalloprotease inhibitors
11/19/1997	EP0807112A1 Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials
11/19/1997	EP0807111A1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
11/19/1997	EP0807110A1 Enterokinetic benzamide
11/19/1997	EP0807109A1 Substituted 1,4-piperazine-heteroaryl derivatives as 5-ht 1d? receptor agonists
11/19/1997	EP0807105A1 Pyridopyrimidones, quinolines and fused n-heretocycles as bradykinin antagonists
11/19/1997	EP0807104A2 Heterocyclic compounds possessing 5ht 2c? receptor antagonist activity
11/19/1997	EP0807101A1 2-aminoindans as selective dopamine d3 ligands
11/19/1997	EP0806966A1 Cationic copolymers of vinylamine and vinyl alcohol for the delivery of oligonucleotides
11/19/1997	EP0806964A1 Chemical compounds
11/19/1997	EP0806963A1 Carcinoma treatment
11/19/1997	EP0806958A1 Inhibition of platelet binding
11/19/1997	EP0806957A1 Combination therapy for hiv infection using the hiv protease inhibitor indinavir adn the reverse transcriptase inhibitor 3tc, optionally together with azt, ddi or ddc
11/19/1997	EP0806956A1 Use of 5'substituted nucleosides to provide resistance in cytostatic treatment and medicaments containing said nucleosides
11/19/1997	EP0806955A1 Enrofloxacine injection or infusion solutions
11/19/1997	EP0806954A1 Inhibition of the degradation of connective tissue matrix protein components in mammals
11/19/1997	EP0806953A2 Agent for acting upon bone formation disturbances containing alkaline citrates, lactates and/or malates
11/19/1997	EP0806952A1 Progesterone antagonists useful for preparing medicaments for treating dysfunctional uterine bleeding
11/19/1997	EP0806951A1 Novel medical use of heme products
11/19/1997	EP0806950A1 Methods of inhibiting environmental estrogens
11/19/1997	EP0806949A1 New pharmaceutical composition containing trimebutine and preparation process
11/19/1997	EP0806948A1 Treating urinary incontinence using (s)-oxybutynin and (s)-desethyloxybutynin
11/19/1997	EP0806947A1 Formulations and methods for reducing skin irritation
11/19/1997	EP0806946A2 Use of carotinoids for preparing medicaments for treating dermatoses
11/19/1997	EP0806943A1 Valaciclovir tablets containing colloidal silicon dioxide
11/19/1997	EP0806941A1 Low rigidity liposomal antibacterial composition

1 ... 6722 6723 6724 6725 6726 6727 6728 6729 6730 6731 6732 6733 6734 6735 6736 6737 6738 6739 6740 6741 6742 ... 7860